Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
by
Maeda, Shin
in
Review
2010
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Do you wish to request the book?
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
by
Maeda, Shin
in
Review
2010
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
Journal Article
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
2010
Request Book From Autostore
and Choose the Collection Method
Overview
Hepatocellular carcinoma (HCC) is the third largest cause of cancer deaths worldwide. The role of molecular changes in HCC have been used to identify prognostic markers and chemopreventive or therapeutic targets. It seems that toll-like receptors (TLRs) as well as the nuclear factor (NF)-κB, and JNK pathways are critical regulators for the production of the cytokines associated with tumor promotion. The cross-talk between an inflammatory cell and a neoplastic cell, which is instigated by the activation of NF-κB and JNKs, is critical for tumor organization. JNKs also regulate cell proliferation and act as oncogenes, making them the main tumor-promoting protein kinases. TLRs play roles in cytokine and hepatomitogen expression mainly in myeloid cells and may promote liver tumorigenesis. A better understanding of these signaling pathways in the liver will help us understand the mechanism of hepatocarcinogenesis and provide a new therapeutic target for HCC.
Publisher
Hindawi Puplishing Corporation,Hindawi Publishing Corporation,Wiley
Subject
This website uses cookies to ensure you get the best experience on our website.